Authors:
CALLAS DD
BERMES EW
OESER T
KAHN SE
HOLMES EW
Citation: Dd. Callas et al., EFFECT OF AGE, SEX, ORAL-CONTRACEPTIVES AND VITAMIN SUPPLEMENTS ON THE SERUM TOTAL HOMOCYSTEINE CONCENTRATION, Clinical chemistry, 44, 1998, pp. 583-583
Authors:
FASANELLA A
HOPPENSTEADT D
WOLF H
BERMES EW
Citation: A. Fasanella et al., PHARMACOKINETICS OF THE COMPARATIVE TFPI RELEASE BY LOW-MOLECULAR-WEIGHT HEPARINS (LMWHS) AS MEASURED BY USING A HIGHLY SENSITIVE ELISA METHOD, Thrombosis and haemostasis, 1997, pp. 1672-1672
Authors:
CALLAS DD
CLARK TL
MOREIRA PL
LANSDEN C
GAWRYL MS
KAHN S
BERMES EW
Citation: Dd. Callas et al., IN-VITRO EFFECTS OF A NOVEL HEMOGLOBIN-BASED OXYGEN CARRIER ON ROUTINE CHEMISTRY, THERAPEUTIC DRUG, COAGULATION, HEMATOLOGY, AND BLOOD-BANKASSAYS, Clinical chemistry, 43(9), 1997, pp. 1744-1748
Authors:
KAHN SE
WARD KA
GALBRAITH KA
CALLAS DD
BANGAYAN L
AUGUSTINE GA
BERMES EW
Citation: Se. Kahn et al., CLINICAL UTILITY OF CARDIAC TROPONIN-I MEASUREMENTS IN THE DIAGNOSIS OF ACUTE MYOCARDIAL-INFARCTION AND IMPLEMENTATION OF THEIR USE IN AN ACADEMIC-MEDICAL-CENTER, Clinical chemistry, 43, 1997, pp. 66-66
Citation: Ew. Holmes et Ew. Bermes, INHIBITION OF IFNY INDUCED INDOLEAMINE DIOXYGENASE (IDO) BY CA IONOPHORE, SPHINGOLIPIDS, AND NSAIDS, The FASEB journal, 10(6), 1996, pp. 2501-2501
Authors:
KAHN S
WOLF H
HOPPENSTEADT DA
WALENGA JM
GALBRAITH E
BERMES EW
FAREED J
Citation: S. Kahn et al., DIAGNOSTIC-VALUE OF TROPONIN-T AS A MARKER OF MYOCARDIAL INJURY IN ACUTE AND CHRONIC CORONARY SYNDROMES, Clinical chemistry, 42(6), 1996, pp. 330-330
Authors:
FASANELLA A
HOPPENSTEADT DA
WOLF H
BERMES EW
FAREED J
Citation: A. Fasanella et al., PHARMACOKINETICS (PK) OF THE COMPARATIVE TFPI RELEASE BY LOW-MOLECULAR-WEIGHT HEPARINS (LMWHS) AS MEASURED BY USING A HIGHLY SENSITIVE ELISA METHOD, Clinical chemistry, 42(6), 1996, pp. 409-409
Authors:
JESKE W
HOPPENSTEADT D
BERMES EW
FASANELLA A
FAREED J
Citation: W. Jeske et al., SPECIFIC QUANTITATION OF HEPARIN-RELEASABLE MULTIDOMAIN KUNITZ-TYPE INHIBITOR (TFPI) DURING PROPHYLACTIC AND THERAPEUTIC USE OF ANTICOAGULANTS, Clinical chemistry, 42(6), 1996, pp. 410-410
Authors:
KOZA MJ
HOPPENSTEADT DA
WALENGA JM
FAREED J
BERMES EW
PIFARRE R
Citation: Mj. Koza et al., EFFECT OF A GLYCOPROTEIN IIB IIIA INHIBITOR ON PLATELET ACTIVATION AND AGGREGATION AS MEASURED BY AGGREGOMETRY AND WHOLE-BLOOD FLOW-CYTOMETRY/, Clinical chemistry, 42(6), 1996, pp. 411-411
Authors:
KOZA MJ
WALENGA JM
HOPPENSTEADT DA
BERMES EW
FAREED J
Citation: Mj. Koza et al., MEASUREMENT OF THE ANTICOAGULANT EFFECT OF WARFARIN IN THE PRESENCE OF AN ANTITHROMBIN AGENT USING AMIDOLYTIC FACTOR-X ASSAY, Clinical chemistry, 42(6), 1996, pp. 412-412
Authors:
IQBAL O
HOPPENSTEADT DA
KOZA MJ
BERMES EW
WALENGA JM
FAREED J
Citation: O. Iqbal et al., MOLECULAR MARKERS OF HEMOSTATIC AND VASCULAR ABBERATIONS IN THE ELDERLY AND THEIR PREDICTIVE VALUE FOR THE DIAGNOSIS OF THROMBOTIC DISORDERS, Clinical chemistry, 42(6), 1996, pp. 413-413
Authors:
FASANELLA A
HOPPENSTEADT D
WOLF H
BERMES EW
FAREED J
Citation: A. Fasanella et al., PHARMACOKINETICS (PK) OF THE COMPARATIVE TFPI RELEASE BY LOW-MOLECULAR-WEIGHT HEPARINS (LWMHS) AS MEASURED BY USING A HIGHLY SENSITIVE ELISA METHOD, Blood, 88(10), 1996, pp. 3050-3050
Authors:
FAREED J
BICK RL
HOPPENSTEADT DA
BERMES EW
Citation: J. Fareed et al., MOLECULAR MARKERS OF HEMOSTATIC ACTIVATION - APPLICATIONS IN THE DIAGNOSIS OF THROMBOSIS AND VASCULAR AND THROMBOTIC DISORDERS, Clinical and applied thrombosis/hemostasis, 1(2), 1995, pp. 87-102
Authors:
HOPPENSTEADT DA
JESKE W
FAREED J
BERMES EW
Citation: Da. Hoppensteadt et al., THE ROLE OF TISSUE FACTOR PATHWAY INHIBITOR IN THE MEDIATION OF THE ANTITHROMBOTIC ACTIONS OF HEPARIN AND LOW-MOLECULAR-WEIGHT HEPARIN, Blood coagulation & fibrinolysis, 6, 1995, pp. 57-64
Citation: Ew. Holmes et Ew. Bermes, NSAIDS MODULATE INTERFERON-GAMMA-INDUCED OXIDATIVE TRYPTOPHAN-METABOLISM IN FIBROBLASTS, The FASEB journal, 9(4), 1995, pp. 954-954
Authors:
HOPPENSTEADT D
KOZA M
WALENGA JM
LEYA F
PIFARRE R
BERMES EW
Citation: D. Hoppensteadt et al., THE ROLE OF TISSUE FACTOR PATHWAY INHIBITOR (TFPI) IN THE MEDIATION OF THE ANTITHROMBOTIC ACTIONS OF HEPARIN AND LOW-MOLECULAR-WEIGHT HEPARIN, Thrombosis and haemostasis, 73(6), 1995, pp. 944-944
Authors:
KOZA MJ
HOLNESS S
WALENGA JM
SHANKEY TV
REILLY T
BERMES EW
PIFARRE R
Citation: Mj. Koza et al., GLYCOPROTEIN-IIB IIIA INHIBITOR ON PLATELET-AGGREGATION AND ACTIVATION AS DETERMINED BY PLATELET AGGREGOMETRY AND FLOW CYTOMETRIC ANALYSIS/, Thrombosis and haemostasis, 73(6), 1995, pp. 996-996
Authors:
KOZA MJ
WALENGA JM
SHANKEY TV
FAREED J
BERMES EW
PIFARRE R
Citation: Mj. Koza et al., TISSUE FACTOR IS CAPABLE OF ACTIVATING CYCLOOXYGENASE COMPROMISED PLATELETS - IMPLICATIONS IN INTERVENTIONAL CARDIOVASCULAR PROCEDURES, Thrombosis and haemostasis, 73(6), 1995, pp. 997-997
Authors:
COYNE E
MESSMORE H
WALENGA JM
HOPPENSTEADT D
FARID S
WEHRMACHER W
BERMES EW
Citation: E. Coyne et al., FISH SKIN GLYCOSAMINOGLYCANS - A SOURCE FOR HIGHLY-ACTIVE HEAVILY SULFATED CHONDROITIN SULFATES, Thrombosis and haemostasis, 73(6), 1995, pp. 1351-1351
Authors:
FAREED J
BICK RL
HOPPENSTEADT DA
WALENGA JM
MESSMORE HL
BERMES EW
Citation: J. Fareed et al., MOLECULAR MARKERS OF HEMOSTATIC ACTIVATION - IMPLICATIONS IN THE DIAGNOSIS OF THROMBOSIS, VASCULAR, AND CARDIOVASCULAR DISORDERS, Clinics in laboratory medicine, 15(1), 1995, pp. 39-61
Authors:
WALENGA JM
HOPPENSTEADT D
KOZA M
FAREED J
PIFARRE R
BERMES EW
Citation: Jm. Walenga et al., TISSUE FACTOR (TF) AND HEPARIN-RELEASABLE TISSUE FACTOR PATHWAY INHIBITOR (TFPI) DURING INTERVENTIONAL CARDIOVASCULAR PROCEDURES, Clinical chemistry, 41(6), 1995, pp. 55-56